Can sulfasalazine prevent infection-mediated pre-term birth in a murine model?
SASP reduced rates of pre-term delivery and improved pregnancy outcomes for mice infected with 10(4) CFU E. coli. This suggests that SASP has the potential to play a role in strategies to prevent pre-term birth in women.
FXR might be a new molecular marker to predict the prognosis of patients with GBC and a novel therapeutic target.